IL-6 modulation for COVID-19: the right patients at the right time?

Ascierto, PA; Fu, BQ; Wei, HM

Ascierto, PA (corresponding author), Ist Nazl Tumori IRCCS Fdn Pascale, Unit Melanoma Canc Immunotherapy & Dev Therapeut, Naples, Italy.

JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021; 9 (4):

Abstract

The ongoing pandemic caused by the novel coronavirus SARS-CoV-2 has disrupted the global economy and strained healthcare systems to their limits. Afte......

Full Text Link